“From the AbbVie situation, I understand that one opportunity cost is time. The longer something takes, the longer you wait, the greater the likelihood that you may not get it done,” Dr. Ornskov says.
http://www.wsj.com/articles/shire-deepens-push-into-biotech-after-abbvie-drops-bid-1436821429?mod=yahoo_hs
http://www.wsj.com/articles/shire-deepens-push-into-biotech-after-abbvie-drops-bid-1436821429?mod=yahoo_hs
No comments:
Post a Comment